IP Library › Granted Patent US 11,814,637
Granted Patent B2
US 11,814,637 · App. 16/498,447 · Granted Nov 14, 2023

Expression modulating elements and use thereof

Inventors: Shane E Abbitt (Ankeny, IA); Mary J Frank (Des Moines, IA); Thomas W Greene (West Des Moines, IA); Nandini Krishnamurthy (Grimes, IA); Andrew Rupiper (Bondurant, IA)
C12N15/8274C12N15/8216C12N15/8286
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,814,637
App. No.
16/498,447
Granted
Nov 14, 2023
Kind
B2
Abstract

The disclosure relates to gene expression modulation elements from plants and their use in modulating the expression of one or more heterologous nucleic acid fragments in plants. The disclosure further discloses compositions, polynucleotide constructs, transformed host cells, plants and seeds containing the expression modulating elements, and methods for preparing and using the same.

Claims (14)

1. A method of modulating expression of an endogenous polynucleotide in a plant cell, the method comprising altering one or more nucleotides in a regulatory region of the endogenous polynucleotide such that the regulatory region of the polynucleotide comprises an expression modulating element having at least one copy of a polynucleotide sequence selected from the group consisting of SEQ ID NOS: 1, 2, 40 and 41.

2. The method of claim 1 , wherein the alteration of one or more nucleotides is by genome modification.

3. The method of claim 1 , wherein the expression modulation element is present within about 10 to about 5000 bp from a transcriptional start site of the endogenous polynucleotide.

4. The method of claim 1 , wherein the expression modulation element further comprises additional copies of the expression modulating element such that about 2× to 10× copies of the expression modulating elements are present in the regulatory region of the endogenous polynucleotide.

5. The method of claim 4 , wherein the additional copies of the expression modulating element are present in one or more of the configurations selected from the group consisting of: head to head, head to tail, tail to head, tail to tail, and a combination thereof.

6. The method of claim 4 , wherein the additional copies are separated by a spacer sequence.

7. The method of claim 1 , wherein the expression modulating element is plant-derived and is heterologous to the endogenous polynucleotide.

8. The method of claim 4 , wherein the additional copies of the expression modulating element is created by altering no more than 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 27, 38, 39 or 40 nucleotides in the regulatory region of the endogenous polynucleotide.

9. The method of claim 1 , wherein the expression modulating element is located upstream of the transcriptional start site of the endogenous polynucleotide.

10. The method of claim 1 , wherein the expression of the endogenous polynucleotide is increased in the plant cell compared to a control plant cell not comprising the expression modulation element operably linked to the endogenous polynucleotide.

11. The method of claim 1 , wherein the plant cell is maize, rice, soybean, sunflower, wheat, canola or sorghum.

12. The method of claim 1 , wherein the endogenous polynucleotide is involved in drought tolerance, disease resistance, herbicide tolerance, pest resistance, yield increase, yield stability, nitrogen utilization efficiency or a combination thereof.

13. The method of claim 2 , wherein the genome modification is (a) a site-specific double strand break (DSB) mediated by a polynucleotide-guided endonuclease, zinc finger nuclease, a transcription activator-like effector nuclease (TALEN), polynucleotide-guided recombinase or engineered site-specific meganucleases, or Argonaute or (b) a site-specific base edit mediated by an C⋅G to T⋅A or a A⋅T to G⋅C base editing deaminase enzymes.

14. The method of claim 1 , wherein the expression modulating element is operably linked to a heterologous minimal core promoter.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2019
From: ABBITT, SHANE E.; FRANK, MARY J; GREENE, THOMAS W.; RUPIPER, ANDREW; KRISHNAMURTHY, NANDINI
To: PIONEER HI-BRED INTERNATIONAL, INC.
Reel/Frame 050510/0230 →
Continuity (2)
Provisional Application 62479781 · Mar 31, 2017
Related Publication 20210324401A1 · Oct 21, 2021